nodes	percent_of_prediction	percent_of_DWPC	metapath
Flucloxacillin—CYP3A4—Bexarotene—hematologic cancer	0.0554	0.0829	CbGbCtD
Flucloxacillin—CYP3A4—Lomustine—hematologic cancer	0.0515	0.0771	CbGbCtD
Flucloxacillin—CYP3A4—Busulfan—hematologic cancer	0.0515	0.0771	CbGbCtD
Flucloxacillin—CYP3A4—Thiotepa—hematologic cancer	0.0459	0.0687	CbGbCtD
Flucloxacillin—CYP3A4—Methoxsalen—hematologic cancer	0.0357	0.0534	CbGbCtD
Flucloxacillin—CYP3A4—Bortezomib—hematologic cancer	0.034	0.0508	CbGbCtD
Flucloxacillin—CYP3A4—Daunorubicin—hematologic cancer	0.0325	0.0486	CbGbCtD
Flucloxacillin—CYP3A4—Cytarabine—hematologic cancer	0.0287	0.0429	CbGbCtD
Flucloxacillin—CYP3A4—Teniposide—hematologic cancer	0.0282	0.0422	CbGbCtD
Flucloxacillin—CYP3A4—Ifosfamide—hematologic cancer	0.026	0.039	CbGbCtD
Flucloxacillin—CYP3A4—Imatinib—hematologic cancer	0.0249	0.0372	CbGbCtD
Flucloxacillin—CYP3A4—Ruxolitinib—hematologic cancer	0.0234	0.0351	CbGbCtD
Flucloxacillin—CYP3A4—Nilotinib—hematologic cancer	0.0226	0.0338	CbGbCtD
Flucloxacillin—CYP3A4—Vinorelbine—hematologic cancer	0.0224	0.0335	CbGbCtD
Flucloxacillin—CYP3A4—Triamcinolone—hematologic cancer	0.0205	0.0307	CbGbCtD
Flucloxacillin—CYP3A4—Dasatinib—hematologic cancer	0.02	0.0299	CbGbCtD
Flucloxacillin—CYP3A4—Mitoxantrone—hematologic cancer	0.0197	0.0295	CbGbCtD
Flucloxacillin—CYP3A4—Betamethasone—hematologic cancer	0.0176	0.0263	CbGbCtD
Flucloxacillin—CYP3A4—Prednisolone—hematologic cancer	0.0174	0.026	CbGbCtD
Flucloxacillin—CYP3A4—Prednisone—hematologic cancer	0.0164	0.0245	CbGbCtD
Flucloxacillin—CYP3A4—Irinotecan—hematologic cancer	0.0155	0.0233	CbGbCtD
Flucloxacillin—CYP3A4—Vinblastine—hematologic cancer	0.0138	0.0207	CbGbCtD
Flucloxacillin—CYP3A4—Vincristine—hematologic cancer	0.0136	0.0203	CbGbCtD
Flucloxacillin—CYP3A4—Etoposide—hematologic cancer	0.0124	0.0186	CbGbCtD
Flucloxacillin—CYP3A4—Dexamethasone—hematologic cancer	0.0102	0.0153	CbGbCtD
Flucloxacillin—CYP3A4—Doxorubicin—hematologic cancer	0.00849	0.0127	CbGbCtD
Flucloxacillin—Dermatitis—Carmustine—hematologic cancer	8.98e-05	0.000271	CcSEcCtD
Flucloxacillin—Vomiting—Alitretinoin—hematologic cancer	8.98e-05	0.000271	CcSEcCtD
Flucloxacillin—Feeling abnormal—Prednisolone—hematologic cancer	8.96e-05	0.00027	CcSEcCtD
Flucloxacillin—Anaemia—Prednisone—hematologic cancer	8.95e-05	0.00027	CcSEcCtD
Flucloxacillin—Headache—Carmustine—hematologic cancer	8.93e-05	0.000269	CcSEcCtD
Flucloxacillin—Rash—Alitretinoin—hematologic cancer	8.9e-05	0.000269	CcSEcCtD
Flucloxacillin—Nervous system disorder—Betamethasone—hematologic cancer	8.9e-05	0.000268	CcSEcCtD
Flucloxacillin—Nervous system disorder—Dexamethasone—hematologic cancer	8.9e-05	0.000268	CcSEcCtD
Flucloxacillin—Dermatitis—Alitretinoin—hematologic cancer	8.89e-05	0.000268	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	8.89e-05	0.000268	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Dexamethasone—hematologic cancer	8.88e-05	0.000268	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Betamethasone—hematologic cancer	8.88e-05	0.000268	CcSEcCtD
Flucloxacillin—Vomiting—Ifosfamide—hematologic cancer	8.87e-05	0.000268	CcSEcCtD
Flucloxacillin—Hypersensitivity—Cisplatin—hematologic cancer	8.86e-05	0.000267	CcSEcCtD
Flucloxacillin—Headache—Alitretinoin—hematologic cancer	8.85e-05	0.000267	CcSEcCtD
Flucloxacillin—Angioedema—Prednisone—hematologic cancer	8.84e-05	0.000267	CcSEcCtD
Flucloxacillin—Diarrhoea—Gemcitabine—hematologic cancer	8.83e-05	0.000266	CcSEcCtD
Flucloxacillin—Nausea—Thalidomide—hematologic cancer	8.81e-05	0.000266	CcSEcCtD
Flucloxacillin—Renal failure—Doxorubicin—hematologic cancer	8.81e-05	0.000266	CcSEcCtD
Flucloxacillin—Dyspepsia—Triamcinolone—hematologic cancer	8.8e-05	0.000265	CcSEcCtD
Flucloxacillin—Rash—Ifosfamide—hematologic cancer	8.8e-05	0.000265	CcSEcCtD
Flucloxacillin—Dermatitis—Ifosfamide—hematologic cancer	8.79e-05	0.000265	CcSEcCtD
Flucloxacillin—Erythema multiforme—Methotrexate—hematologic cancer	8.79e-05	0.000265	CcSEcCtD
Flucloxacillin—Dizziness—Irinotecan—hematologic cancer	8.76e-05	0.000264	CcSEcCtD
Flucloxacillin—Urticaria—Etoposide—hematologic cancer	8.76e-05	0.000264	CcSEcCtD
Flucloxacillin—Jaundice—Doxorubicin—hematologic cancer	8.74e-05	0.000264	CcSEcCtD
Flucloxacillin—Malaise—Prednisone—hematologic cancer	8.73e-05	0.000263	CcSEcCtD
Flucloxacillin—Abdominal pain—Etoposide—hematologic cancer	8.71e-05	0.000263	CcSEcCtD
Flucloxacillin—Body temperature increased—Etoposide—hematologic cancer	8.71e-05	0.000263	CcSEcCtD
Flucloxacillin—Hepatitis—Epirubicin—hematologic cancer	8.7e-05	0.000262	CcSEcCtD
Flucloxacillin—Vomiting—Vincristine—hematologic cancer	8.65e-05	0.000261	CcSEcCtD
Flucloxacillin—Urticaria—Prednisolone—hematologic cancer	8.64e-05	0.000261	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Epirubicin—hematologic cancer	8.59e-05	0.000259	CcSEcCtD
Flucloxacillin—Rash—Vincristine—hematologic cancer	8.58e-05	0.000259	CcSEcCtD
Flucloxacillin—Dermatitis—Vincristine—hematologic cancer	8.57e-05	0.000259	CcSEcCtD
Flucloxacillin—Haematuria—Doxorubicin—hematologic cancer	8.55e-05	0.000258	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Epirubicin—hematologic cancer	8.55e-05	0.000258	CcSEcCtD
Flucloxacillin—Urethral disorder—Epirubicin—hematologic cancer	8.52e-05	0.000257	CcSEcCtD
Flucloxacillin—Headache—Vincristine—hematologic cancer	8.52e-05	0.000257	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Doxorubicin—hematologic cancer	8.48e-05	0.000256	CcSEcCtD
Flucloxacillin—Nausea—Carmustine—hematologic cancer	8.47e-05	0.000255	CcSEcCtD
Flucloxacillin—Vomiting—Irinotecan—hematologic cancer	8.42e-05	0.000254	CcSEcCtD
Flucloxacillin—Vomiting—Mitoxantrone—hematologic cancer	8.42e-05	0.000254	CcSEcCtD
Flucloxacillin—Immune system disorder—Methotrexate—hematologic cancer	8.39e-05	0.000253	CcSEcCtD
Flucloxacillin—Nausea—Alitretinoin—hematologic cancer	8.39e-05	0.000253	CcSEcCtD
Flucloxacillin—Convulsion—Prednisone—hematologic cancer	8.39e-05	0.000253	CcSEcCtD
Flucloxacillin—Agranulocytosis—Doxorubicin—hematologic cancer	8.36e-05	0.000252	CcSEcCtD
Flucloxacillin—Rash—Mitoxantrone—hematologic cancer	8.35e-05	0.000252	CcSEcCtD
Flucloxacillin—Rash—Irinotecan—hematologic cancer	8.35e-05	0.000252	CcSEcCtD
Flucloxacillin—Dermatitis—Irinotecan—hematologic cancer	8.35e-05	0.000252	CcSEcCtD
Flucloxacillin—Dermatitis—Mitoxantrone—hematologic cancer	8.35e-05	0.000252	CcSEcCtD
Flucloxacillin—Headache—Mitoxantrone—hematologic cancer	8.3e-05	0.00025	CcSEcCtD
Flucloxacillin—Headache—Irinotecan—hematologic cancer	8.3e-05	0.00025	CcSEcCtD
Flucloxacillin—Nausea—Ifosfamide—hematologic cancer	8.29e-05	0.00025	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	8.26e-05	0.000249	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Betamethasone—hematologic cancer	8.26e-05	0.000249	CcSEcCtD
Flucloxacillin—Myalgia—Prednisone—hematologic cancer	8.24e-05	0.000249	CcSEcCtD
Flucloxacillin—Arthralgia—Prednisone—hematologic cancer	8.24e-05	0.000249	CcSEcCtD
Flucloxacillin—Feeling abnormal—Triamcinolone—hematologic cancer	8.24e-05	0.000249	CcSEcCtD
Flucloxacillin—Diarrhoea—Cisplatin—hematologic cancer	8.23e-05	0.000248	CcSEcCtD
Flucloxacillin—Erythema multiforme—Epirubicin—hematologic cancer	8.22e-05	0.000248	CcSEcCtD
Flucloxacillin—Vomiting—Gemcitabine—hematologic cancer	8.21e-05	0.000248	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	8.18e-05	0.000247	CcSEcCtD
Flucloxacillin—Discomfort—Prednisone—hematologic cancer	8.14e-05	0.000246	CcSEcCtD
Flucloxacillin—Rash—Gemcitabine—hematologic cancer	8.14e-05	0.000245	CcSEcCtD
Flucloxacillin—Dermatitis—Gemcitabine—hematologic cancer	8.13e-05	0.000245	CcSEcCtD
Flucloxacillin—Hypersensitivity—Etoposide—hematologic cancer	8.12e-05	0.000245	CcSEcCtD
Flucloxacillin—Headache—Gemcitabine—hematologic cancer	8.09e-05	0.000244	CcSEcCtD
Flucloxacillin—Nausea—Vincristine—hematologic cancer	8.08e-05	0.000244	CcSEcCtD
Flucloxacillin—Hepatitis—Doxorubicin—hematologic cancer	8.05e-05	0.000243	CcSEcCtD
Flucloxacillin—Hypersensitivity—Prednisolone—hematologic cancer	8.01e-05	0.000242	CcSEcCtD
Flucloxacillin—Dyspepsia—Dexamethasone—hematologic cancer	7.98e-05	0.000241	CcSEcCtD
Flucloxacillin—Dyspepsia—Betamethasone—hematologic cancer	7.98e-05	0.000241	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Doxorubicin—hematologic cancer	7.95e-05	0.00024	CcSEcCtD
Flucloxacillin—Urticaria—Triamcinolone—hematologic cancer	7.94e-05	0.00024	CcSEcCtD
Flucloxacillin—Dysgeusia—Methotrexate—hematologic cancer	7.92e-05	0.000239	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Doxorubicin—hematologic cancer	7.91e-05	0.000239	CcSEcCtD
Flucloxacillin—Body temperature increased—Triamcinolone—hematologic cancer	7.9e-05	0.000238	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Prednisone—hematologic cancer	7.9e-05	0.000238	CcSEcCtD
Flucloxacillin—Urethral disorder—Doxorubicin—hematologic cancer	7.89e-05	0.000238	CcSEcCtD
Flucloxacillin—Decreased appetite—Dexamethasone—hematologic cancer	7.89e-05	0.000238	CcSEcCtD
Flucloxacillin—Decreased appetite—Betamethasone—hematologic cancer	7.89e-05	0.000238	CcSEcCtD
Flucloxacillin—Nausea—Irinotecan—hematologic cancer	7.87e-05	0.000237	CcSEcCtD
Flucloxacillin—Nausea—Mitoxantrone—hematologic cancer	7.87e-05	0.000237	CcSEcCtD
Flucloxacillin—Immune system disorder—Epirubicin—hematologic cancer	7.85e-05	0.000237	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Betamethasone—hematologic cancer	7.83e-05	0.000236	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	7.83e-05	0.000236	CcSEcCtD
Flucloxacillin—Nervous system disorder—Prednisone—hematologic cancer	7.75e-05	0.000234	CcSEcCtD
Flucloxacillin—Skin disorder—Prednisone—hematologic cancer	7.67e-05	0.000231	CcSEcCtD
Flucloxacillin—Nausea—Gemcitabine—hematologic cancer	7.67e-05	0.000231	CcSEcCtD
Flucloxacillin—Vomiting—Cisplatin—hematologic cancer	7.65e-05	0.000231	CcSEcCtD
Flucloxacillin—Erythema multiforme—Doxorubicin—hematologic cancer	7.61e-05	0.000229	CcSEcCtD
Flucloxacillin—Rash—Cisplatin—hematologic cancer	7.59e-05	0.000229	CcSEcCtD
Flucloxacillin—Dermatitis—Cisplatin—hematologic cancer	7.58e-05	0.000229	CcSEcCtD
Flucloxacillin—Diarrhoea—Etoposide—hematologic cancer	7.54e-05	0.000227	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Methotrexate—hematologic cancer	7.51e-05	0.000226	CcSEcCtD
Flucloxacillin—Anaemia—Methotrexate—hematologic cancer	7.48e-05	0.000226	CcSEcCtD
Flucloxacillin—Feeling abnormal—Dexamethasone—hematologic cancer	7.47e-05	0.000225	CcSEcCtD
Flucloxacillin—Feeling abnormal—Betamethasone—hematologic cancer	7.47e-05	0.000225	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Betamethasone—hematologic cancer	7.42e-05	0.000224	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Dexamethasone—hematologic cancer	7.42e-05	0.000224	CcSEcCtD
Flucloxacillin—Dysgeusia—Epirubicin—hematologic cancer	7.41e-05	0.000224	CcSEcCtD
Flucloxacillin—Hypersensitivity—Triamcinolone—hematologic cancer	7.37e-05	0.000222	CcSEcCtD
Flucloxacillin—Malaise—Methotrexate—hematologic cancer	7.29e-05	0.00022	CcSEcCtD
Flucloxacillin—Dizziness—Etoposide—hematologic cancer	7.29e-05	0.00022	CcSEcCtD
Flucloxacillin—Immune system disorder—Doxorubicin—hematologic cancer	7.27e-05	0.000219	CcSEcCtD
Flucloxacillin—Leukopenia—Methotrexate—hematologic cancer	7.24e-05	0.000218	CcSEcCtD
Flucloxacillin—Urticaria—Betamethasone—hematologic cancer	7.21e-05	0.000217	CcSEcCtD
Flucloxacillin—Urticaria—Dexamethasone—hematologic cancer	7.21e-05	0.000217	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Prednisone—hematologic cancer	7.2e-05	0.000217	CcSEcCtD
Flucloxacillin—Dizziness—Prednisolone—hematologic cancer	7.19e-05	0.000217	CcSEcCtD
Flucloxacillin—Body temperature increased—Dexamethasone—hematologic cancer	7.17e-05	0.000216	CcSEcCtD
Flucloxacillin—Abdominal pain—Dexamethasone—hematologic cancer	7.17e-05	0.000216	CcSEcCtD
Flucloxacillin—Abdominal pain—Betamethasone—hematologic cancer	7.17e-05	0.000216	CcSEcCtD
Flucloxacillin—Body temperature increased—Betamethasone—hematologic cancer	7.17e-05	0.000216	CcSEcCtD
Flucloxacillin—Nausea—Cisplatin—hematologic cancer	7.15e-05	0.000216	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Epirubicin—hematologic cancer	7.02e-05	0.000212	CcSEcCtD
Flucloxacillin—Convulsion—Methotrexate—hematologic cancer	7.01e-05	0.000211	CcSEcCtD
Flucloxacillin—Vomiting—Etoposide—hematologic cancer	7.01e-05	0.000211	CcSEcCtD
Flucloxacillin—Anaemia—Epirubicin—hematologic cancer	7e-05	0.000211	CcSEcCtD
Flucloxacillin—Dyspepsia—Prednisone—hematologic cancer	6.95e-05	0.00021	CcSEcCtD
Flucloxacillin—Rash—Etoposide—hematologic cancer	6.95e-05	0.00021	CcSEcCtD
Flucloxacillin—Dermatitis—Etoposide—hematologic cancer	6.94e-05	0.000209	CcSEcCtD
Flucloxacillin—Headache—Etoposide—hematologic cancer	6.9e-05	0.000208	CcSEcCtD
Flucloxacillin—Arthralgia—Methotrexate—hematologic cancer	6.89e-05	0.000208	CcSEcCtD
Flucloxacillin—Myalgia—Methotrexate—hematologic cancer	6.89e-05	0.000208	CcSEcCtD
Flucloxacillin—Decreased appetite—Prednisone—hematologic cancer	6.87e-05	0.000207	CcSEcCtD
Flucloxacillin—Dysgeusia—Doxorubicin—hematologic cancer	6.86e-05	0.000207	CcSEcCtD
Flucloxacillin—Rash—Prednisolone—hematologic cancer	6.85e-05	0.000207	CcSEcCtD
Flucloxacillin—Dermatitis—Prednisolone—hematologic cancer	6.85e-05	0.000207	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	6.84e-05	0.000206	CcSEcCtD
Flucloxacillin—Malaise—Epirubicin—hematologic cancer	6.83e-05	0.000206	CcSEcCtD
Flucloxacillin—Headache—Prednisolone—hematologic cancer	6.81e-05	0.000205	CcSEcCtD
Flucloxacillin—Discomfort—Methotrexate—hematologic cancer	6.8e-05	0.000205	CcSEcCtD
Flucloxacillin—Leukopenia—Epirubicin—hematologic cancer	6.78e-05	0.000204	CcSEcCtD
Flucloxacillin—Constipation—Prednisone—hematologic cancer	6.76e-05	0.000204	CcSEcCtD
Flucloxacillin—Dizziness—Triamcinolone—hematologic cancer	6.61e-05	0.000199	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Methotrexate—hematologic cancer	6.6e-05	0.000199	CcSEcCtD
Flucloxacillin—Convulsion—Epirubicin—hematologic cancer	6.56e-05	0.000198	CcSEcCtD
Flucloxacillin—Nausea—Etoposide—hematologic cancer	6.55e-05	0.000197	CcSEcCtD
Flucloxacillin—Feeling abnormal—Prednisone—hematologic cancer	6.51e-05	0.000196	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Doxorubicin—hematologic cancer	6.5e-05	0.000196	CcSEcCtD
Flucloxacillin—Nervous system disorder—Methotrexate—hematologic cancer	6.47e-05	0.000195	CcSEcCtD
Flucloxacillin—Anaemia—Doxorubicin—hematologic cancer	6.47e-05	0.000195	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Methotrexate—hematologic cancer	6.46e-05	0.000195	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Prednisone—hematologic cancer	6.46e-05	0.000195	CcSEcCtD
Flucloxacillin—Nausea—Prednisolone—hematologic cancer	6.46e-05	0.000195	CcSEcCtD
Flucloxacillin—Myalgia—Epirubicin—hematologic cancer	6.44e-05	0.000194	CcSEcCtD
Flucloxacillin—Arthralgia—Epirubicin—hematologic cancer	6.44e-05	0.000194	CcSEcCtD
Flucloxacillin—Skin disorder—Methotrexate—hematologic cancer	6.41e-05	0.000193	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	6.4e-05	0.000193	CcSEcCtD
Flucloxacillin—Discomfort—Epirubicin—hematologic cancer	6.37e-05	0.000192	CcSEcCtD
Flucloxacillin—Vomiting—Triamcinolone—hematologic cancer	6.36e-05	0.000192	CcSEcCtD
Flucloxacillin—Malaise—Doxorubicin—hematologic cancer	6.32e-05	0.000191	CcSEcCtD
Flucloxacillin—Rash—Triamcinolone—hematologic cancer	6.3e-05	0.00019	CcSEcCtD
Flucloxacillin—Dermatitis—Triamcinolone—hematologic cancer	6.3e-05	0.00019	CcSEcCtD
Flucloxacillin—Urticaria—Prednisone—hematologic cancer	6.28e-05	0.000189	CcSEcCtD
Flucloxacillin—Leukopenia—Doxorubicin—hematologic cancer	6.27e-05	0.000189	CcSEcCtD
Flucloxacillin—Headache—Triamcinolone—hematologic cancer	6.26e-05	0.000189	CcSEcCtD
Flucloxacillin—Body temperature increased—Prednisone—hematologic cancer	6.24e-05	0.000188	CcSEcCtD
Flucloxacillin—Abdominal pain—Prednisone—hematologic cancer	6.24e-05	0.000188	CcSEcCtD
Flucloxacillin—Diarrhoea—Dexamethasone—hematologic cancer	6.21e-05	0.000187	CcSEcCtD
Flucloxacillin—Diarrhoea—Betamethasone—hematologic cancer	6.21e-05	0.000187	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Epirubicin—hematologic cancer	6.18e-05	0.000186	CcSEcCtD
Flucloxacillin—Convulsion—Doxorubicin—hematologic cancer	6.07e-05	0.000183	CcSEcCtD
Flucloxacillin—Nervous system disorder—Epirubicin—hematologic cancer	6.06e-05	0.000183	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Epirubicin—hematologic cancer	6.05e-05	0.000182	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	6.01e-05	0.000181	CcSEcCtD
Flucloxacillin—Skin disorder—Epirubicin—hematologic cancer	6e-05	0.000181	CcSEcCtD
Flucloxacillin—Dizziness—Betamethasone—hematologic cancer	6e-05	0.000181	CcSEcCtD
Flucloxacillin—Dizziness—Dexamethasone—hematologic cancer	6e-05	0.000181	CcSEcCtD
Flucloxacillin—Myalgia—Doxorubicin—hematologic cancer	5.96e-05	0.00018	CcSEcCtD
Flucloxacillin—Arthralgia—Doxorubicin—hematologic cancer	5.96e-05	0.00018	CcSEcCtD
Flucloxacillin—Nausea—Triamcinolone—hematologic cancer	5.94e-05	0.000179	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	5.92e-05	0.000179	CcSEcCtD
Flucloxacillin—Discomfort—Doxorubicin—hematologic cancer	5.89e-05	0.000178	CcSEcCtD
Flucloxacillin—Hypersensitivity—Prednisone—hematologic cancer	5.82e-05	0.000176	CcSEcCtD
Flucloxacillin—Dyspepsia—Methotrexate—hematologic cancer	5.81e-05	0.000175	CcSEcCtD
Flucloxacillin—Vomiting—Betamethasone—hematologic cancer	5.77e-05	0.000174	CcSEcCtD
Flucloxacillin—Vomiting—Dexamethasone—hematologic cancer	5.77e-05	0.000174	CcSEcCtD
Flucloxacillin—Decreased appetite—Methotrexate—hematologic cancer	5.74e-05	0.000173	CcSEcCtD
Flucloxacillin—Rash—Betamethasone—hematologic cancer	5.72e-05	0.000173	CcSEcCtD
Flucloxacillin—Rash—Dexamethasone—hematologic cancer	5.72e-05	0.000173	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Doxorubicin—hematologic cancer	5.72e-05	0.000172	CcSEcCtD
Flucloxacillin—Dermatitis—Betamethasone—hematologic cancer	5.71e-05	0.000172	CcSEcCtD
Flucloxacillin—Dermatitis—Dexamethasone—hematologic cancer	5.71e-05	0.000172	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Methotrexate—hematologic cancer	5.7e-05	0.000172	CcSEcCtD
Flucloxacillin—Headache—Dexamethasone—hematologic cancer	5.68e-05	0.000171	CcSEcCtD
Flucloxacillin—Headache—Betamethasone—hematologic cancer	5.68e-05	0.000171	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	5.63e-05	0.00017	CcSEcCtD
Flucloxacillin—Nervous system disorder—Doxorubicin—hematologic cancer	5.61e-05	0.000169	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Doxorubicin—hematologic cancer	5.6e-05	0.000169	CcSEcCtD
Flucloxacillin—Skin disorder—Doxorubicin—hematologic cancer	5.55e-05	0.000167	CcSEcCtD
Flucloxacillin—Feeling abnormal—Methotrexate—hematologic cancer	5.44e-05	0.000164	CcSEcCtD
Flucloxacillin—Dyspepsia—Epirubicin—hematologic cancer	5.44e-05	0.000164	CcSEcCtD
Flucloxacillin—Diarrhoea—Prednisone—hematologic cancer	5.4e-05	0.000163	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Methotrexate—hematologic cancer	5.4e-05	0.000163	CcSEcCtD
Flucloxacillin—Nausea—Dexamethasone—hematologic cancer	5.39e-05	0.000163	CcSEcCtD
Flucloxacillin—Nausea—Betamethasone—hematologic cancer	5.39e-05	0.000163	CcSEcCtD
Flucloxacillin—Decreased appetite—Epirubicin—hematologic cancer	5.37e-05	0.000162	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Epirubicin—hematologic cancer	5.33e-05	0.000161	CcSEcCtD
Flucloxacillin—Constipation—Epirubicin—hematologic cancer	5.28e-05	0.000159	CcSEcCtD
Flucloxacillin—Urticaria—Methotrexate—hematologic cancer	5.24e-05	0.000158	CcSEcCtD
Flucloxacillin—Dizziness—Prednisone—hematologic cancer	5.22e-05	0.000158	CcSEcCtD
Flucloxacillin—Abdominal pain—Methotrexate—hematologic cancer	5.22e-05	0.000157	CcSEcCtD
Flucloxacillin—Body temperature increased—Methotrexate—hematologic cancer	5.22e-05	0.000157	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	5.21e-05	0.000157	CcSEcCtD
Flucloxacillin—Feeling abnormal—Epirubicin—hematologic cancer	5.09e-05	0.000154	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Epirubicin—hematologic cancer	5.05e-05	0.000152	CcSEcCtD
Flucloxacillin—Dyspepsia—Doxorubicin—hematologic cancer	5.03e-05	0.000152	CcSEcCtD
Flucloxacillin—Vomiting—Prednisone—hematologic cancer	5.02e-05	0.000152	CcSEcCtD
Flucloxacillin—Rash—Prednisone—hematologic cancer	4.98e-05	0.00015	CcSEcCtD
Flucloxacillin—Dermatitis—Prednisone—hematologic cancer	4.98e-05	0.00015	CcSEcCtD
Flucloxacillin—Decreased appetite—Doxorubicin—hematologic cancer	4.97e-05	0.00015	CcSEcCtD
Flucloxacillin—Headache—Prednisone—hematologic cancer	4.95e-05	0.000149	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	4.94e-05	0.000149	CcSEcCtD
Flucloxacillin—Urticaria—Epirubicin—hematologic cancer	4.91e-05	0.000148	CcSEcCtD
Flucloxacillin—Constipation—Doxorubicin—hematologic cancer	4.89e-05	0.000147	CcSEcCtD
Flucloxacillin—Abdominal pain—Epirubicin—hematologic cancer	4.88e-05	0.000147	CcSEcCtD
Flucloxacillin—Body temperature increased—Epirubicin—hematologic cancer	4.88e-05	0.000147	CcSEcCtD
Flucloxacillin—Hypersensitivity—Methotrexate—hematologic cancer	4.86e-05	0.000147	CcSEcCtD
Flucloxacillin—Feeling abnormal—Doxorubicin—hematologic cancer	4.71e-05	0.000142	CcSEcCtD
Flucloxacillin—Nausea—Prednisone—hematologic cancer	4.69e-05	0.000142	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.67e-05	0.000141	CcSEcCtD
Flucloxacillin—Hypersensitivity—Epirubicin—hematologic cancer	4.55e-05	0.000137	CcSEcCtD
Flucloxacillin—Urticaria—Doxorubicin—hematologic cancer	4.54e-05	0.000137	CcSEcCtD
Flucloxacillin—Abdominal pain—Doxorubicin—hematologic cancer	4.52e-05	0.000136	CcSEcCtD
Flucloxacillin—Body temperature increased—Doxorubicin—hematologic cancer	4.52e-05	0.000136	CcSEcCtD
Flucloxacillin—Diarrhoea—Methotrexate—hematologic cancer	4.52e-05	0.000136	CcSEcCtD
Flucloxacillin—Dizziness—Methotrexate—hematologic cancer	4.37e-05	0.000132	CcSEcCtD
Flucloxacillin—Diarrhoea—Epirubicin—hematologic cancer	4.23e-05	0.000128	CcSEcCtD
Flucloxacillin—Hypersensitivity—Doxorubicin—hematologic cancer	4.21e-05	0.000127	CcSEcCtD
Flucloxacillin—Vomiting—Methotrexate—hematologic cancer	4.2e-05	0.000127	CcSEcCtD
Flucloxacillin—Rash—Methotrexate—hematologic cancer	4.16e-05	0.000126	CcSEcCtD
Flucloxacillin—Dermatitis—Methotrexate—hematologic cancer	4.16e-05	0.000125	CcSEcCtD
Flucloxacillin—Headache—Methotrexate—hematologic cancer	4.14e-05	0.000125	CcSEcCtD
Flucloxacillin—Dizziness—Epirubicin—hematologic cancer	4.09e-05	0.000123	CcSEcCtD
Flucloxacillin—Vomiting—Epirubicin—hematologic cancer	3.93e-05	0.000118	CcSEcCtD
Flucloxacillin—Nausea—Methotrexate—hematologic cancer	3.92e-05	0.000118	CcSEcCtD
Flucloxacillin—Diarrhoea—Doxorubicin—hematologic cancer	3.91e-05	0.000118	CcSEcCtD
Flucloxacillin—Rash—Epirubicin—hematologic cancer	3.9e-05	0.000118	CcSEcCtD
Flucloxacillin—Dermatitis—Epirubicin—hematologic cancer	3.89e-05	0.000117	CcSEcCtD
Flucloxacillin—Headache—Epirubicin—hematologic cancer	3.87e-05	0.000117	CcSEcCtD
Flucloxacillin—Dizziness—Doxorubicin—hematologic cancer	3.78e-05	0.000114	CcSEcCtD
Flucloxacillin—Nausea—Epirubicin—hematologic cancer	3.67e-05	0.000111	CcSEcCtD
Flucloxacillin—Vomiting—Doxorubicin—hematologic cancer	3.63e-05	0.00011	CcSEcCtD
Flucloxacillin—Rash—Doxorubicin—hematologic cancer	3.6e-05	0.000109	CcSEcCtD
Flucloxacillin—Dermatitis—Doxorubicin—hematologic cancer	3.6e-05	0.000109	CcSEcCtD
Flucloxacillin—Headache—Doxorubicin—hematologic cancer	3.58e-05	0.000108	CcSEcCtD
Flucloxacillin—Nausea—Doxorubicin—hematologic cancer	3.4e-05	0.000102	CcSEcCtD
